US Patent Issued to SWEDISH ORPHAN BIOVITRUM on May 13 for "Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications" (Swiss Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,264, issued on May 13, was assigned to SWEDISH ORPHAN BIOVITRUM AG (Switzerland).

"Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications" was invented by Cristina De Min (Basel, Switzerland), Walter Ferlin (Basel, Switzerland) and Fabrizio De Benedetti (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates generally to methods compositions and dosing regimens for treating, preventing and/or delaying the onset or progression of, or alleviating a symptom associated with elevated IFN-Gamma levels."

The patent was filed on July 25, 2023, under Application No. 18/358,...